Home
About
Overview
Sharing Data
ORCID
Help
History (20)
Surgical phenotype of patients with peritoneal mesothelioma and a germline mutation.
X-Ray Microtomography
A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma.
Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.
Understanding Mechanisms of Robust Information Processing by NF-kappaB
See All 20 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Understanding Mechanisms of Robust Information Processing by NF-kappaB
Overview
sponsor award id
R01GM128042
Biography
contributor
Principal Investigator
Time
start date
2018-05-01
end date
2024-03-31